{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:58:29Z","timestamp":1775195909067,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2026.e00850","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T21:53:05Z","timestamp":1770760385000},"page":"e00850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Treatment of Psychiatric Disorders in Patients with HIV"],"prefix":"10.1016","volume":"23","author":[{"given":"Glenn J.","family":"Treisman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce E.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neurot.2026.e00850_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0033-3182(93)71847-2","article-title":"Psychiatric care of patients infected with HIV. The varying perspectives","volume":"34","author":"Treisman","year":"1993","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neurot.2026.e00850_bib2","first-page":"239","article-title":"Evaluation and treatment of psychiatric disorders associated with HIV infection","volume":"72","author":"Treisman","year":"1993"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00850_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2190\/URTC-AQVJ-N9KG-0RL4","article-title":"Screening for psychiatric disorders in an HIV medical clinic: the importance of a psychiatric presence","volume":"24","author":"Lyketsos","year":"1994","journal-title":"The International Journal of Psychiatry in Medicine"},{"key":"10.1016\/j.neurot.2026.e00850_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2025.112311","article-title":"Beyond total depressive symptoms: differential associations between depressive domains, HIV status and disease characteristics","volume":"196","author":"Prescott","year":"2025","journal-title":"J Psychosom Res"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00850_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0033-3182(97)71419-1","article-title":"The effectiveness of psychiatric treatment for HIV-infected patients","volume":"38","author":"Lyketsos","year":"1997","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neurot.2026.e00850_bib6","article-title":"Factors associated with initial medication adherence with first-line therapy for depression","volume":"1","author":"Ganna","year":"2025","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00850_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264503","article-title":"Association of depression and antidepressant therapy with antiretroviral therapy adherence and health-related quality of life in men who have sex with men","volume":"17","author":"Yen","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e00850_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119815","article-title":"Sociodemographic and clinical factors associated with use of depression treatment among people with HIV in the United States: an electronic health records-based cohort study","volume":"390","author":"Metz","year":"2025","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00850_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.18865\/EthnDis-2024-17","article-title":"Mental health and cognitive performance Among older people living with HIV in Georgia","volume":"35","author":"Imerlishvili","year":"2025","journal-title":"Ethn Dis"},{"key":"10.1016\/j.neurot.2026.e00850_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-025-04725-8","article-title":"Amphetamine-Type stimulant use and associated factors Among men Who have sex with men in Bangkok","author":"Boonruang","year":"2025","journal-title":"AIDS Behav"},{"key":"10.1016\/j.neurot.2026.e00850_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-025-04815-7","article-title":"Recent alcohol use influences associations between cortisol levels and negative affect: the New Orleans alcohol use in HIV Study","author":"Fitzpatrick-Schmidt","year":"2025","journal-title":"AIDS Behav"},{"key":"10.1016\/j.neurot.2026.e00850_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/hiv.70090","article-title":"KIULARCO Study Group. Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: a prospective cohort study","author":"Ndege","year":"2025","journal-title":"HIV Med"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00850_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13365-021-00960-6","article-title":"Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage","volume":"27","author":"Denton","year":"2021","journal-title":"J Neurovirol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00850_bib14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/infdis\/jiad558","article-title":"Distinct effects of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors on soluble biomarkers in blood and cerebrospinal fluid of people With HIV","volume":"229","author":"Trunfio","year":"2024","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00850_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40264-021-01048-0","article-title":"Comparison of medication alerts from two commercial applications in the USA","volume":"44","author":"Shah","year":"2021","journal-title":"Drug Saf"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00850_bib16","first-page":"1104","article-title":"HIV risk activity among persons with severe mental illness: preliminary findings","volume":"44","author":"Cournos","year":"1993","journal-title":"Hosp Community Psychiatry"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00850_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/QAD.0000000000003554","article-title":"Time to get it right: investing in the mental wellbeing of people living with HIV","volume":"37","author":"Pence","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.neurot.2026.e00850_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2025.104883","article-title":"\"It makes all the sense in the world\": a qualitative evaluation of patient perspectives on implementation outcomes of a peer-facilitated integrated infectious disease and substance use care model","volume":"143","author":"Brown","year":"2025","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.neurot.2026.e00850_bib19","series-title":"Manual of the Eysenck personality questionnaire","author":"Eysenck","year":"1975"},{"issue":"427","key":"10.1016\/j.neurot.2026.e00850_bib20","first-page":"427","article-title":"Learning and lawyering across personality types","volume":"21","author":"Weinstein","year":"2015","journal-title":"Clin Law Rev"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00850_bib21","first-page":"65","article-title":"Personality characteristics and Their relationship to HIV-Risk, behavior, compliance, and treatment","volume":"6","author":"Hutton","year":"1999","journal-title":"Prim Psychiatry"},{"issue":"16","key":"10.1016\/j.neurot.2026.e00850_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM197804202981605","article-title":"Taking care of the hateful patient","volume":"298","author":"Groves","year":"1978","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00850_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0376-8716(02)00011-X","article-title":"Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder","volume":"67","author":"Linehan","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00850_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-4603(82)90038-7","article-title":"Self-change and therapy change of smoking behavior: a comparison of processes of change in cessation and maintenance","volume":"7","author":"DiClemente","year":"1982","journal-title":"Addict Behav"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:06:20Z","timestamp":1775189180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747926000206"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00850","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Treatment of Psychiatric Disorders in Patients with HIV","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00850"}}